Abstract:The oceans cover about 96.5% of all the Earth's water and are virtually unexploited resources for novel drug discovery. Members of almost every phylum are found in the oceans, whereas twelve phyla are exclusively marine. A very limited fraction of marine compounds have been tested in clinically relevant bioassays. Higher resistance of pathogenic microorganisms to antibiotics and disease cells to antitumor medications requires a new phase of novel medicines. The study aims to explore the potential of marine sponges as natural inhibitors for breast cancer therapy using an optimized in-silico technique. We perform in -silico analysis for around two hundred and seventy-two (272) marine sponge compounds against ERα of breast cancer using molecular docking and dynamics techniques. The results of the current study were carefully used to screen the compounds with the potential to inhibit ERα of breast cancer. For instance, molecular docking analysis reveals that six top-hit selected ligands L1 (Di(IH-indol-3-yl) methanone), L2 (1,2-Bis (1H-indol-3-yl)ethane-1,2-dione), L3 2-(4-benzylpiperidin-1-yl)1-(1H-indol-3-yl)ethenone), L4 ( 5H-Pyrido[4,3-b]carbazole-5,11(6H)-dione), L5 (4H-pyrido[2,3,4-Kl]acridine-4-one), and L6 15-methyl-2, 12,15-triazapentacyclo [11.7.1.03,8,09,21.014,19]henicosa-1,3,5,7,9(21),10,12,14(19),16-nonaene-18,20-dione) show docking scores values ranging from -9.2 kcal/mole to -9.5 kcal/mol in comparison to reference drug inhibitor -8.6 kcal/mole to -9.5 kcal/mol. For comparison purposes, reference drug candidates like tamoxifen, ospemifene, and quinestrol have been studied under the same in -silico methodology. The ligand-protein interactions displayed various types of intermolecular interactions, including hydrogen bond formationand hydrophobic and π-π stacking interactions towards the active site of the protein. Explicit molecular dynamic (MD) simulations for 120 ns were executed to mimic the in-vitro aqueous environment and stability pattern of ligand-protein complexes through RMSD, RMSF, Rg, SASA, and intermolecular H-bond. Furthermore, MM/PBSA calculation also confirmed the good binding free energy ( ΔGbind ) of L1 (-22.63 kcal/mol), L2 (-13.81 kcal/mol), L3 (-19.23 kcal/mol), L4 (-24.50 kcal/mol), L5 (-14.44 kcal/mol), and L6 (-8.16 kcal/mol) towards ERα (1gwr). Additionally, the ADMET prediction of top-hit ligands was observed to have good drug-likeness criteria (Lipinski RO5) and pharmacokinetic properties. The in-silico approach identified ligands L1, L2, L3, L4, L5 , and L6 as a promising inhibitor of ERα of breast cancer, suggesting in vivo/in vitro studies to investigate their inhibitory potentials further.

Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro

Anti-Tumor Activity vs. Normal Cell Toxicity: Therapeutic Potential of the Bromotyrosines Aerothionin and Homoaerothionin In Vitro

Pro-Apoptotic Activity of the Marine Sponge Dactylospongia elegans Metabolites Pelorol and 5- epi-Ilimaquinone on Human 501Mel Melanoma Cells

Anticancer potential of Spirastrella pachyspira (marine sponge) against SK-BR-3 human breast cancer cell line and in silico analysis of its bioactive molecule sphingosine

Peniciketal A, A Novel Spiroketal Compound, Exerts Anticancer Effects by Inhibiting Cell Proliferation, Migration and Invasion of A549 Lung Cancer Cells.

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Antiproliferative Cyclodepsipeptides from the Marine Actinomycete Streptomyces Sp. P11-23B Downregulating the Tumor Metabolic Enzymes of Glycolysis, Glutaminolysis, and Lipogenesis.

SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/mTOR Signaling Pathways

Anti-Proliferative Potential of Secondary Metabolites from the Marine Sponge Theonella sp.: Moving from Correlation toward Causation

High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action-A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay

A Multi-Targeting Natural Product, Aiphanol, Inhibits Tumor Growth and Metastasis.

Exploring the Untapped Potential of Marine Sponge Compounds as Anticancer Agents against ERα of Breast Cancer

Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review

Isolation and Assessment of the in Vitro Anti-Tumor Activity of Smenothiazole A and B, Chlorinated Thiazole-Containing Peptide/Polyketides from the Caribbean Sponge, Smenospongia aurea

Non-Anticoagulant Heparan Sulfate from the Ascidian Phallusia nigra Prevents Colon Carcinoma Metastasis in Mice by Disrupting Platelet-Tumor Cell Interaction

Exploring the seas for cancer cures: the promise of marine-derived bioactive peptide

A Novel Anticancer Peptide Derived from Bryopsis plumosa Regulates Proliferation and Invasion in Non-Small Cell Lung Cancer Cells

Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase

Green synthesized extracts/Au complex of Phyllospongia lamellosa: Unrevealing the anti-cancer and anti-bacterial potentialities, supported by metabolomics and molecular modeling

Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth and Metastasis via Blocking Cell Adhesion and Attenuating Filiform Structure Formation

Mechanisms of Antitumor Invasion and Metastasis of the Marine Fungal Derivative Epi-Aszonalenin A in HT1080 Cells